We are live on
!
Find out more
ACM
Alethea Capital Management Portfolio holdings
AUM
$195M
1-Year Est. Return
51.17%
This Fund
S&P 500
This Quarter
Est. Return
+8.04%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$199M
AUM Growth
+$51.7M
(+35%)
Cap. Flow
+$44.1M
Cap. Flow
% of AUM
22.11%
Top 10 Holdings %
Top 10 Hldgs %
80.63%
Holding
91
New
26
Increased
4
Reduced
18
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$45.8M |
| 2 |
SPDR Gold Trust
GLD
|
+$1.88M |
| 3 |
Chubb
CB
|
+$1.64M |
| 4 |
Morgan Stanley
MS
|
+$1.63M |
| 5 |
GRMN
Garmin
GRMN
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$2.98M |
| 2 |
Gen Digital
GEN
|
+$1.69M |
| 3 |
Kura Oncology
KURA
|
+$1.69M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$1.63M |
| 5 |
General Mills
GIS
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 68.26% |
| 2 | Financials | 7.82% |
| 3 | Consumer Staples | 2.73% |
| 4 | Technology | 2.04% |
| 5 | Industrials | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axsome Therapeutics
AXSM
$12.4B
| $82.3M | 41.25% |
1,009,799
+668
| +0.1% | +$50K |
|
|
RNAM
2
DELISTED
Avidity Biosciences
RNAM
| $40.1M | 20.1% |
+1,571,160
| New | +$45.8M |
|
|
3
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
| $16.9M | 8.46% |
184,284
-32,568
| -15% | -$2.98M |
|
4
Capital One
COF
$124B
| $5.72M | 2.87% |
57,837
| – | – |
|
|
SPPI
5
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $5.25M | 2.63% |
1,539,949
+62,737
| +4% | +$258K |
|
|
CDTX
6
DELISTED
Cidara Therapeutics
CDTX
| $2.31M | 1.16% |
57,707
-7
| -0% | -$348 |
|
7
iShares 0-1 Year Treasury Bond ETF
SHV
$20.7B
| $2.27M | 1.14% |
20,534
| – | – |
|
|
8
Kura Oncology
KURA
$922M
| $2.21M | 1.11% |
67,568
-48,073
| -42% | -$1.69M |
|
|
9
Morgan Stanley
MS
$337B
| $1.94M | 0.97% |
+28,363
| New | +$1.63M |
|
|
10
SPDR Gold Trust
GLD
$131B
| $1.9M | 0.95% |
+10,653
| New | +$1.88M |
|
|
11
Chubb
CB
$140B
| $1.8M | 0.9% |
+11,666
| New | +$1.64M |
|
|
GRMN
12
Garmin
GRMN
$46.9B
| $1.72M | 0.86% |
+14,363
| New | +$1.59M |
|
13
Everest Group
EG
$15.2B
| $1.6M | 0.8% |
+6,844
| New | +$1.51M |
|
14
Alexandria Real Estate Equities
ARE
$8.88B
| $1.5M | 0.75% |
+8,419
| New | +$1.39M |
|
15
Conagra Brands
CAG
$7.07B
| $1.37M | 0.69% |
37,779
-6,971
| -16% | -$253K |
|
16
AbbVie
ABBV
$458B
| $1.32M | 0.66% |
+12,338
| New | +$1.19M |
|
17
iShares Russell 2000 ETF
IWM
$80.9B
| $1.03M | 0.52% |
+5,250
| New | +$919K |
|
18
iShares Silver Trust
SLV
$28.1B
| $1.03M | 0.52% |
+41,831
| New | +$951K |
|
19
Citigroup
C
$222B
| $995K | 0.5% |
+16,134
| New | +$820K |
|
20
Evergy
EVRG
$20.1B
| $941K | 0.47% |
+16,951
| New | +$930K |
|
21
Petrobras
PBR
$121B
| $937K | 0.47% |
+83,399
| New | +$740K |
|
22
Western Union
WU
$2.57B
| $868K | 0.44% |
+39,562
| New | +$858K |
|
23
Kraft Heinz
KHC
$30.4B
| $798K | 0.4% |
23,029
-9,603
| -29% | -$312K |
|
24
Alphabet (Google) Class C
GOOG
$3.9T
| $739K | 0.37% |
8,440
-160
| -2% | -$13.5K |
|
25
Bank of America
BAC
$435B
| $725K | 0.36% |
23,924
-707
| -3% | -$18.9K |
|
Similar funds
WM
LWA
CPI
WAL
NLWP
ICMARC
RAM
MHFA
Alethea Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Alethea Capital Management held 91 positions worth $199M, up 35% from $148M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Alethea Capital Management deployed $44.1M of net new capital in Q4 2020, opening 26 new positions and adding to 4 existing holdings. Its largest new stake was Avidity Biosciences: 1,571,160 shares worth $40.1M.
By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 62% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $2.98M trimmed.
- Alethea Capital Management's largest Q4 2020 buy was Avidity Biosciences: 1,571,160 shares worth $40.1M.
- Alethea Capital Management added most to ExxonMobil in Q4 2020, an estimated $274K increase.
- Alethea Capital Management's biggest Q4 2020 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $2.98M.
- Alethea Capital Management fully exited Gen Digital in Q4 2020, selling an estimated $1.69M.
- Alethea Capital Management's ten largest holdings make up 81% of its $199M portfolio in Q4 2020.
- Alethea Capital Management opened 26 new positions and closed 17 in Q4 2020.
- Alethea Capital Management's portfolio value rose 35% quarter-over-quarter to $199M.
Based on Alethea Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.